Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

PD-L1 and calcitriol dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.

Galea R, Nel H, Talekar M, Liu X, Ooi JD, Huynh M, Hadjigol S, Robson KJ, Ting YT, Cole S, Cochlin K, Hitchcock S, Zeng B, Yekollu S, Boks M, Goh N, Roberts H, Rossjohn J, Reid HH, Boyd BJ, Malaviya R, Shealy DJ, Baker DG, Madakamutil L, Kitching AR, O'Sullivan BJ, Thomas R.

JCI Insight. 2019 Sep 5. pii: 126025. doi: 10.1172/jci.insight.126025. [Epub ahead of print]

2.

Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.

Odobasic D, Oudin V, Ito K, Gan PY, Kitching AR, Holdsworth SR.

J Am Soc Nephrol. 2019 Aug 23. pii: ASN.2019030236. doi: 10.1681/ASN.2019030236. [Epub ahead of print]

PMID:
31444274
3.

Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis.

Gan PY, Chan A, Ooi JD, Dick J, Nagai K, O'Sullivan KM, Oudin V, Shim R, Kitching AR, Holdsworth SR.

Kidney Int. 2019 May 27. pii: S0085-2538(19)30531-9. doi: 10.1016/j.kint.2019.05.012. [Epub ahead of print]

PMID:
31443998
4.

A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.

Ooi JD, Jiang JH, Eggenhuizen PJ, Chua LL, van Timmeren M, Loh KL, O'Sullivan KM, Gan PY, Zhong Y, Tsyganov K, Shochet LR, Ryan J, Stegeman CA, Fugger L, Reid HH, Rossjohn J, Heeringa P, Holdsworth SR, Peleg AY, Kitching AR.

Nat Commun. 2019 Jul 29;10(1):3392. doi: 10.1038/s41467-019-11255-0.

5.

Apoptotic Cell-Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN.

Gan PY, Godfrey AS, Ooi JD, O'Sullivan KM, Oudin V, Kitching AR, Holdsworth SR.

J Am Soc Nephrol. 2019 Aug;30(8):1365-1374. doi: 10.1681/ASN.2018090955. Epub 2019 Jul 23.

PMID:
31337690
6.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Carter SA, Lightstone L, Cattran D, Bagga A, Barbour SJ, Barratt J, Boletis J, Caster D, Coppo R, Fervenza FC, Floege J, Hladunewich M, Hogan JJ, Kitching AR, Lafayette R, Malvar A, Radhakrishnan J, Rovin BH, Zhang H, Gutman T, Howell M, Logeman C, Shen JI, Teixeira-Pinto A, Alexander SI, Cho Y, Craig JC, Harris D, Johnson DW, Kerr PG, Ryan J, Viecelli AK, Wang AY, Wilkie M, Scholes-Robertson N, Tong A; SONG-GD Initiative.

Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047. No abstract available.

PMID:
31122702
7.

HLA-DR15-specific inhibition attenuates autoreactivity to the Goodpasture antigen.

Huynh M, Eggenhuizen PJ, Olson GL, Rao NB, Self CR, Sun Y, Holdsworth SR, Kitching AR, Ooi JD.

J Autoimmun. 2019 Sep;103:102276. doi: 10.1016/j.jaut.2019.05.004. Epub 2019 May 16.

PMID:
31104947
8.

Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus.

Jiang SH, Athanasopoulos V, Ellyard JI, Chuah A, Cappello J, Cook A, Prabhu SB, Cardenas J, Gu J, Stanley M, Roco JA, Papa I, Yabas M, Walters GD, Burgio G, McKeon K, Byers JM, Burrin C, Enders A, Miosge LA, Canete PF, Jelusic M, Tasic V, Lungu AC, Alexander SI, Kitching AR, Fulcher DA, Shen N, Arsov T, Gatenby PA, Babon JJ, Mallon DF, de Lucas Collantes C, Stone EA, Wu P, Field MA, Andrews TD, Cho E, Pascual V, Cook MC, Vinuesa CG.

Nat Commun. 2019 May 17;10(1):2201. doi: 10.1038/s41467-019-10242-9.

9.

The renal draining lymph nodes in acute inflammatory kidney disease.

Kitching AR, Holdsworth SR.

Kidney Int. 2019 Feb;95(2):254-256. doi: 10.1016/j.kint.2018.10.011.

PMID:
30665562
10.

Platelet retention in inflamed glomeruli occurs via selective prolongation of interactions with immune cells.

Finsterbusch M, Norman MU, Hall P, Kitching AR, Hickey MJ.

Kidney Int. 2019 Feb;95(2):363-374. doi: 10.1016/j.kint.2018.08.042. Epub 2018 Dec 3.

PMID:
30522769
11.

Inflammasomes in the Kidney.

Hutton HL, Alikhan MA, Kitching AR.

Exp Suppl. 2018;108:177-210. doi: 10.1007/978-3-319-89390-7_8.

PMID:
30536172
12.

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus.

Vincent FB, Slavin L, Hoi AY, Kitching AR, Mackay F, Harris J, Kandane-Rathnayake R, Morand EF.

Lupus Sci Med. 2018 Oct 19;5(1):e000277. doi: 10.1136/lupus-2018-000277. eCollection 2018.

13.

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.

Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F, Morand EF.

Lupus. 2018 Nov;27(13):2029-2040. doi: 10.1177/0961203318804885. Epub 2018 Oct 9.

PMID:
30301439
14.

HLA and kidney disease: from associations to mechanisms.

Robson KJ, Ooi JD, Holdsworth SR, Rossjohn J, Kitching AR.

Nat Rev Nephrol. 2018 Oct;14(10):636-655. doi: 10.1038/s41581-018-0057-8. Review.

PMID:
30206339
15.

CD8+ cells and glomerular crescent formation: outside-in as well as inside-out.

Kitching AR, Alikhan MA.

J Clin Invest. 2018 Aug 1;128(8):3231-3233. doi: 10.1172/JCI122045. Epub 2018 Jul 9.

16.

OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.

Odobasic D, Ruth AJ, Oudin V, Kitching AR, Holdsworth SR.

Nephrol Dial Transplant. 2019 Mar 1;34(3):429-441. doi: 10.1093/ndt/gfy177.

PMID:
29939347
17.

Chimeric antigen receptor T (CAR T) cells: another cancer therapy with potential applications in kidney disease and transplantation?

Kitching AR, Jaw J.

Kidney Int. 2018 Jul;94(1):4-6. doi: 10.1016/j.kint.2018.05.006. No abstract available.

PMID:
29933855
18.

Intrarenal Toll-like receptor 4 and Toll-like receptor 2 expression correlates with injury in antineutrophil cytoplasmic antibody-associated vasculitis.

O'Sullivan KM, Ford SL, Longano A, Kitching AR, Holdsworth SR.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1283-F1294. doi: 10.1152/ajprenal.00040.2018. Epub 2018 Jun 20.

PMID:
29923769
19.

Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis.

Odobasic D, Jia Y, Kao W, Fan H, Wei X, Gu R, Ngo D, Kitching AR, Holdsworth SR, Morand EF, Yang YH.

Int Immunopharmacol. 2018 Aug;61:140-149. doi: 10.1016/j.intimp.2018.05.028. Epub 2018 Jun 4.

PMID:
29879657
20.

Goodpasture's autoimmune disease - A collagen IV disorder.

Pedchenko V, Kitching AR, Hudson BG.

Matrix Biol. 2018 Oct;71-72:240-249. doi: 10.1016/j.matbio.2018.05.004. Epub 2018 May 12. Review.

21.

Regulatory T cells in renal disease.

Alikhan MA, Huynh M, Kitching AR, Ooi JD.

Clin Transl Immunology. 2018 Jan 30;7(1):e1004. doi: 10.1002/cti2.1004. eCollection 2018. Review.

22.

Effector CD4+ T cells recognize intravascular antigen presented by patrolling monocytes.

Westhorpe CLV, Norman MU, Hall P, Snelgrove SL, Finsterbusch M, Li A, Lo C, Tan ZH, Li S, Nilsson SK, Kitching AR, Hickey MJ.

Nat Commun. 2018 Feb 21;9(1):747. doi: 10.1038/s41467-018-03181-4.

23.

The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis.

Dick J, Gan PY, Kitching AR, Holdsworth SR.

PLoS One. 2018 Jan 9;13(1):e0190655. doi: 10.1371/journal.pone.0190655. eCollection 2018.

24.

Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney disease.

Holdsworth SR, Kitching AR.

Nat Rev Nephrol. 2018 Feb;14(2):76-78. doi: 10.1038/nrneph.2017.171. Epub 2017 Dec 18. Review. No abstract available.

PMID:
29292371
25.

C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.

Dick J, Gan PY, Ford SL, Odobasic D, Alikhan MA, Loosen SH, Hall P, Westhorpe CL, Li A, Ooi JD, Woodruff TM, Mackay CR, Kitching AR, Hickey MJ, Holdsworth SR.

Kidney Int. 2018 Mar;93(3):615-625. doi: 10.1016/j.kint.2017.09.018. Epub 2017 Dec 12.

PMID:
29241626
26.

Renal Dendritic Cells: The Long and Winding Road.

Kitching AR, Ooi JD.

J Am Soc Nephrol. 2018 Jan;29(1):4-7. doi: 10.1681/ASN.2017101145. Epub 2017 Dec 11. No abstract available.

27.

Pathogenic Role for γδ T Cells in Autoimmune Anti-Myeloperoxidase Glomerulonephritis.

Gan PY, Fujita T, Ooi JD, Alikhan MA, Dick J, Shim R, Odobasic D, O'Sullivan KM, Kitching AR, Holdsworth SR.

J Immunol. 2017 Nov 1;199(9):3042-3050. doi: 10.4049/jimmunol.1602025. Epub 2017 Sep 27.

28.

ANCA-Associated Vasculitis: Pathogenesis, Models, and Preclinical Testing.

Hutton HL, Holdsworth SR, Kitching AR.

Semin Nephrol. 2017 Sep;37(5):418-435. doi: 10.1016/j.semnephrol.2017.05.016. Review.

PMID:
28863790
29.

Chyluria: When is proteinuria 'not proteinuria'?

Teo S, LePage A, Kitching AR, Johnstone L.

J Paediatr Child Health. 2017 Oct;53(10):1015-1017. doi: 10.1111/jpc.13655. Epub 2017 Aug 9. No abstract available.

PMID:
28791743
30.

Epstein-Barr virus encephalitis in solid organ transplantation.

Lau JSY, Low ZM, Abbott I, Shochet L, Kanellis J, Kitching AR, Korman TM.

New Microbiol. 2017 Jul;40(3):212-217. Epub 2017 May 17. Review.

31.

Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.

Ooi JD, Petersen J, Tan YH, Huynh M, Willett ZJ, Ramarathinam SH, Eggenhuizen PJ, Loh KL, Watson KA, Gan PY, Alikhan MA, Dudek NL, Handel A, Hudson BG, Fugger L, Power DA, Holt SG, Coates PT, Gregersen JW, Purcell AW, Holdsworth SR, La Gruta NL, Reid HH, Rossjohn J, Kitching AR.

Nature. 2017 May 11;545(7653):243-247. doi: 10.1038/nature22329. Epub 2017 May 3.

32.

Imaging Leukocyte Responses in the Kidney.

Finsterbusch M, Kitching AR, Hickey MJ.

Transplantation. 2017 Mar;101(3):506-516. doi: 10.1097/TP.0000000000001557. Review.

PMID:
28198769
33.

In Vivo Imaging of Inflamed Glomeruli Reveals Dynamics of Neutrophil Extracellular Trap Formation in Glomerular Capillaries.

Westhorpe CL, Bayard JE, O'Sullivan KM, Hall P, Cheng Q, Kitching AR, Hickey MJ.

Am J Pathol. 2017 Feb;187(2):318-331. doi: 10.1016/j.ajpath.2016.10.008. Epub 2016 Dec 18.

PMID:
27998729
34.

Interleukin-17RA Promotes Humoral Responses and Glomerular Injury in Experimental Rapidly Progressive Glomerulonephritis.

Ghali JR, O'Sullivan KM, Eggenhuizen PJ, Holdsworth SR, Kitching AR.

Nephron. 2017;135(3):207-223. doi: 10.1159/000453059. Epub 2016 Dec 10.

PMID:
27941331
35.

From bench to pet shop to bedside? The environment and immune function in mice.

Kitching AR, Ooi JD.

Kidney Int. 2016 Dec;90(6):1142-1143. doi: 10.1016/j.kint.2016.08.017. Epub 2016 Sep 28.

PMID:
27692816
36.

Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.

Ghali JR, Alikhan MA, Holdsworth SR, Kitching AR.

Immunology. 2017 Jan;150(1):100-114. doi: 10.1111/imm.12671. Epub 2016 Oct 10.

37.

Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus.

Finsterbusch M, Hall P, Li A, Devi S, Westhorpe CL, Kitching AR, Hickey MJ.

Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):E5172-81. doi: 10.1073/pnas.1606253113. Epub 2016 Aug 15.

38.

Activated Renal Dendritic Cells Cross Present Intrarenal Antigens After Ischemia-Reperfusion Injury.

Snelgrove SL, Lo C, Hall P, Lo CY, Alikhan MA, Coates PT, Holdsworth SR, Hickey MJ, Kitching AR.

Transplantation. 2017 May;101(5):1013-1024. doi: 10.1097/TP.0000000000001427.

PMID:
27495751
39.

CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.

Chang J, Eggenhuizen P, O'Sullivan KM, Alikhan MA, Holdsworth SR, Ooi JD, Kitching AR.

J Am Soc Nephrol. 2017 Jan;28(1):47-55. doi: 10.1681/ASN.2015121356. Epub 2016 Jun 10.

40.

The Players: Cells Involved in Glomerular Disease.

Kitching AR, Hutton HL.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1664-74. doi: 10.2215/CJN.13791215. Epub 2016 Apr 12.

41.

Corrigendum: Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus.

Devi S, Li A, Westhorpe CL, Lo CY, Abeynaike LD, Snelgrove SL, Hall P, Ooi JD, Sobey CG, Kitching AR, Hickey MJ.

Nat Med. 2016 Apr;22(4):446. doi: 10.1038/nm0416-446a. No abstract available.

PMID:
27050593
42.

The NLRP3 inflammasome in kidney disease and autoimmunity.

Hutton HL, Ooi JD, Holdsworth SR, Kitching AR.

Nephrology (Carlton). 2016 Sep;21(9):736-44. doi: 10.1111/nep.12785. Review.

PMID:
27011059
43.

Biologics for the treatment of autoimmune renal diseases.

Holdsworth SR, Gan PY, Kitching AR.

Nat Rev Nephrol. 2016 Apr;12(4):217-31. doi: 10.1038/nrneph.2016.18. Epub 2016 Mar 7. Review.

PMID:
26949177
44.

Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase.

Odobasic D, Kitching AR, Holdsworth SR.

J Immunol Res. 2016;2016:2349817. doi: 10.1155/2016/2349817. Epub 2016 Jan 20. Review.

45.

Targeting IL-17 and IL-23 in Immune Mediated Renal Disease.

Ghali JR, Holdsworth SR, Kitching AR.

Curr Med Chem. 2015;22(38):4341-65. Review.

PMID:
26521930
46.

Mast Cell Stabilization Ameliorates Autoimmune Anti-Myeloperoxidase Glomerulonephritis.

Gan PY, O'Sullivan KM, Ooi JD, Alikhan MA, Odobasic D, Summers SA, Kitching AR, Holdsworth SR.

J Am Soc Nephrol. 2016 May;27(5):1321-33. doi: 10.1681/ASN.2014090906. Epub 2015 Sep 15.

47.

Regulatory T cells in immune-mediated renal disease.

Ghali JR, Wang YM, Holdsworth SR, Kitching AR.

Nephrology (Carlton). 2016 Feb;21(2):86-96. doi: 10.1111/nep.12574. Review.

PMID:
26206106
48.

Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.

O'Sullivan KM, Lo CY, Summers SA, Elgass KD, McMillan PJ, Longano A, Ford SL, Gan PY, Kerr PG, Kitching AR, Holdsworth SR.

Kidney Int. 2015 Nov;88(5):1030-46. doi: 10.1038/ki.2015.202. Epub 2015 Jul 15.

PMID:
26176828
49.

Endogenous Toll-Like Receptor 9 Regulates AKI by Promoting Regulatory T Cell Recruitment.

Alikhan MA, Summers SA, Gan PY, Chan AJ, Khouri MB, Ooi JD, Ghali JR, Odobasic D, Hickey MJ, Kitching AR, Holdsworth SR.

J Am Soc Nephrol. 2016 Mar;27(3):706-14. doi: 10.1681/ASN.2014090927. Epub 2015 Jun 26.

50.

Myeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GN.

Gan PY, Tan DS, Ooi JD, Alikhan MA, Kitching AR, Holdsworth SR.

J Am Soc Nephrol. 2016 Feb;27(2):385-91. doi: 10.1681/ASN.2015010089. Epub 2015 Jun 5.

Supplemental Content

Loading ...
Support Center